Erlotinib - how does it fare in an unselected population? An NHS Tayside experience

J. Johnstone, E. Brown, H. Lord

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)S9-S9
    Number of pages1
    JournalLung Cancer
    Volume79
    Publication statusPublished - Jan 2013

    Cite this

    Johnstone, J. ; Brown, E. ; Lord, H. / Erlotinib - how does it fare in an unselected population? An NHS Tayside experience. In: Lung Cancer. 2013 ; Vol. 79. pp. S9-S9.
    @article{bd0dcd608d694ddea223db65e2f5833d,
    title = "Erlotinib - how does it fare in an unselected population? An NHS Tayside experience",
    author = "J. Johnstone and E. Brown and H. Lord",
    year = "2013",
    month = "1",
    language = "English",
    volume = "79",
    pages = "S9--S9",
    journal = "Lung Cancer",
    issn = "0169-5002",
    publisher = "Elsevier",

    }

    Johnstone, J, Brown, E & Lord, H 2013, 'Erlotinib - how does it fare in an unselected population? An NHS Tayside experience', Lung Cancer, vol. 79, pp. S9-S9.

    Erlotinib - how does it fare in an unselected population? An NHS Tayside experience. / Johnstone, J.; Brown, E.; Lord, H.

    In: Lung Cancer, Vol. 79, 01.2013, p. S9-S9.

    Research output: Contribution to journalMeeting abstract

    TY - JOUR

    T1 - Erlotinib - how does it fare in an unselected population? An NHS Tayside experience

    AU - Johnstone, J.

    AU - Brown, E.

    AU - Lord, H.

    PY - 2013/1

    Y1 - 2013/1

    M3 - Meeting abstract

    VL - 79

    SP - S9-S9

    JO - Lung Cancer

    JF - Lung Cancer

    SN - 0169-5002

    ER -